Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

Share Price is delayed by 15 minutes
Get Live Data
19.45    -0.65 (-3.23%)
Bid:
19.00
Ask:
19.90
Spread: 0.90 (4.737%)
Market Cap: €111.86b
BVA Live PriceLast checked at - London Stock Exchange

Intraday Bbva Ord Share Chart

"Dividend Option" execution timetable

12 Sep 2014 17:53

RNS Number : 5998R
Banco Bilbao Vizcaya Argentaria SA
12 September 2014
 



Banco Bilbao Vizcaya Argentaria, S.A. (BBVA), in compliance with the Securities Market legislation, hereby proceeds by means of the present document to notify the following:

 

 

RELEVANT EVENT 

 

 

BBVA hereby communicates relevant information relating to the free-of-charge capital increase resolved by the General Meeting of BBVA shareholders held on 14th March 2014, under agenda item four, section 4.2, by which a system of flexible shareholder remuneration called "Dividend Option" is to be instrumented. Accompanying this relevant event notice is an information note related to the Dividend Option.

 

 

 

 

Madrid, 12th September 2014

INFORMATION NOTE

 

 

 

The General Meeting of BBVA shareholders held on 14th March 2014, under agenda item four, section 4.2, approved a free-of-charge capital increase for the instrumentation of the system of shareholder remuneration called "Dividend Option", which permits shareholders to elect to receive their remuneration in BBVA shares or, at their election, in cash.

 

The execution of such free-of-charge capital increase will be proposed for consideration by BBVA's Board of Directors, so that the Dividend Option may be implemented during October.

 

If BBVA's Board of Directors approves the execution of such free-of-charge capital increase in the terms and conditions of the proposal, it is expected to be executed in accordance with the following timetable:

 

· 24th September 2014: Communication of the number of rights necessary to receive one new share, and the definitive price at which BBVA has committed to purchase rights.

 

· 26th September 2014 (23:59 Madrid (Spain) time): Record date for allocation of rights.

 

· 29th September 2014: Rights trading period begins in Spain.

· 8th October 2014: Deadline for requesting payment in cash (sale of rights to BBVA).

 

· 13th October 2014: Rights trading period ends.

 

· 16th October 2014: Payment date to shareholders who have requested payout in cash (sale of rights to BBVA).

 

· 23rd October 2014: New shares allocated to shareholders.

 

· 24th October 2014: Initiation of ordinary trading of the new shares on the Spanish exchanges, subject to obtaining all necessary authorisations.

 

Finally, it is estimated that, assuming BBVA's Board of Directors approves the proposal for the execution of such free-of-charge capital increase, the approximate purchase price at which BBVA will purchase rights, in accordance with the formula approved by the General Meeting of BBVA shareholders, will be around 0.08 euros per right.

 

Madrid, 12th September 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGMLVZZGDZM
Date   Source Headline
31st Oct 20197:00 amRNS3Q19 Results Press Release
21st Oct 20195:05 pmRNS3Q19 Results Presentation Announcement
8th Oct 20197:41 amRNSCorporate Transactions
3rd Oct 20197:00 amRNSDividend October 2019
30th Sep 20197:00 amRNSRelevant Information DCN
24th Sep 20198:15 amRNSPre-Stabilisation Notice - BBVA
29th Aug 20197:00 amRNSOffer of securities contingently convertible
28th Aug 20197:00 amRNSPreferred securities contingently convertible
8th Aug 20197:00 amRNSSale of BBVA Paraguay
5th Aug 201912:07 pmRNSPost-Stabilisation Notice - BBVA
31st Jul 20198:18 amRNS2Q19 Results Report
31st Jul 20198:14 amRNS2Q19 Results Presentation
31st Jul 20197:08 amRNS2Q19 Results Press Release
18th Jul 20195:32 pmRNS2Q19 Results Presentation Announcement
4th Jul 20195:19 pmRNSFitch Ratings upgrade
21st Jun 20195:25 pmRNSTransfer of credits rights
12th Jun 20198:03 amRNSPre-Stabilisation Notice - BBVA
29th Apr 20195:24 pmRNSAppointments at the board of Directors
29th Apr 20195:20 pmRNS1Q19 Results Presentation
29th Apr 20195:08 pmRNS1Q19 Results Press Release
29th Apr 20195:06 pmRNS1Q19 Results Report
26th Apr 201910:41 amRNS2018 Audited Financial Statements
25th Apr 201910:48 amRNSPost Stabilisation Notice
17th Apr 201910:48 amRNS1Q19 Results Presentation Announcement
12th Apr 20197:00 amRNSGlobal Medium Term Programme - Venue change
20th Mar 201910:52 amRNSPost Stabilisation Notice - BBVA
20th Mar 20197:00 amRNSIssue of securities convertible into BBVA shares
19th Mar 201910:42 amRNSPre Stabilisation Notice
18th Mar 20193:42 pmRNSPrudential Relevance Report Pillar III in 2018
18th Mar 20193:36 pmRNSResolutions adopted by the AGM
20th Feb 20197:00 amRNSRedemption of Subordinated Notes
15th Feb 20197:00 amRNSCapital Requirements for 2019
13th Feb 20198:02 amRNS2019 AGM Proposed Resolutions
12th Feb 20197:00 amRNSFinal dividend calendar 2018
11th Feb 20196:07 pmRNS2019 Annual General Meeting Call
1st Feb 20197:00 amRNSFinal dividend for 2018
1st Feb 20197:00 amRNS4Q18 Results Presentation
1st Feb 20197:00 amRNS4Q18 Results Report
1st Feb 20197:00 amRNS4Q18 Results Press Release
28th Jan 20195:38 pmRNS4Q18 Results Presentation Announcement
16th Jan 20197:00 amRNSRedemption of securities contingently convertible
16th Jan 20197:00 amRNSRedemption of securities contingently convertible
27th Dec 20187:00 amRNSAgreement with Voyager Investing UK Limited
24th Dec 20187:00 amRNSBBVA gives full effect to its succession plan
21st Dec 20187:00 amRNSSuccession plans for Executive Chairman and CEO
20th Dec 20187:00 amRNSEstrategy automobile financing business in Chile
17th Dec 20181:03 pmRNSPublication of approved ECP Information Memorandum
28th Nov 20185:17 pmRNSComposition of the Board of Directors
5th Nov 20187:00 amRNS2018 Stress Test by European Banking Authority
30th Oct 20187:00 amRNS3Q18 Results Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.